We are happy to announce that the Montis Capital fund has invested over 7 mln PLN in the Biotts SA. Biotts – a Wroclaw-based startup – is developing innovative carriers of medical substances as well as drug compositions. Its flagship transdermal carrier can transport particles deep into the skin. The Biotech company has also recently signed a multimillion-dollar agreement with Balanced Biotech – together with this American company, Biotts will develop a drug to treat breast cancer. More information here (in polish).
